Skip to search.
 FTSE 100 Down 1.00%

AbbVie Inc. (ABBV)

-NYSE
53.46 Up 0.57(1.08%) 20:36 - NYSE Real Time Price
Prev Close:52.89
Open:52.31
Bid:53.56 x 200
Ask:53.58 x 400
1y Target Est:72.81
Beta:1.59589
Earnings Date:21 Apr - 25 Apr (Est.)
Day's Range:52.04 - 53.94
52wk Range:45.45 - 71.60
Volume:5,826,110
Avg Vol (3m):8,898,270
Market Cap:87.39b
P/E (ttm):17.08
EPS (ttm):3.13
Div & Yield:2.28 (4.29%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ABBVUp 1.08%87.39b
PFEUp 1.58%179.09b
MRKUp 0.88%137.61b

Key Statistics

Forward P/E (1 yr):8.99
P/S (ttm):3.78
Ex-Dividend Date:13-Jan-16

Analysts

Annual EPS Est (Dec-16) :5.02
Quarterly EPS Est (Mar-16) :1.14
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):0.58

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company’s products include HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; VIEKIRA PAK, an all-o... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback